Watchful waiting in low–tumor burden follicular lymphoma in the rituximab era: results of an F2-study database
P Solal-Céligny, M Bellei, L Marcheselli… - Journal of clinical …, 2012 - ascopubs.org
Purpose Patients with follicular lymphoma (FL) registered in the F2-study and initially
managed without treatment were analyzed to describe the presentation and outcome of a …
managed without treatment were analyzed to describe the presentation and outcome of a …
Watchful waiting in low-tumor burden follicular lymphoma in the rituximab era: results of an F2-study database.
P Solal-Céligny, M Bellei, L Marcheselli… - Journal of Clinical …, 2012 - europepmc.org
Purpose Patients with follicular lymphoma (FL) registered in the F2-study and initially
managed without treatment were analyzed to describe the presentation and outcome of a …
managed without treatment were analyzed to describe the presentation and outcome of a …
[PDF][PDF] Watchful Waiting in Low–Tumor Burden Follicular Lymphoma in the Rituximab Era: Results of an F2-Study Database
P Solal-Céligny, M Bellei, L Marcheselli, EA Pesce… - J Clin …, 2012 - angelaserra.com
Purpose Patients with follicular lymphoma (FL) registered in the F2-study and initially
managed without treatment were analyzed to describe the presentation and outcome of a …
managed without treatment were analyzed to describe the presentation and outcome of a …
[引用][C] Watchful Waiting in Low―Tumor Burden Follicular Lymphoma in the Rituximab Era: Results of an F2-Study Database
P SOLAL-CELIGNY, M BELLEI… - Journal of clinical …, 2012 - pascal-francis.inist.fr
Watchful Waiting in Low―Tumor Burden Follicular Lymphoma in the Rituximab Era: Results
of an F2-Study Database CNRS Inist Pascal-Francis CNRS Pascal and Francis …
of an F2-Study Database CNRS Inist Pascal-Francis CNRS Pascal and Francis …
Watchful waiting in low-tumor burden follicular lymphoma in the rituximab era: results of an F2-study database
P Solal-Céligny, M Bellei… - Journal of clinical …, 2012 - pubmed.ncbi.nlm.nih.gov
Purpose Patients with follicular lymphoma (FL) registered in the F2-study and initially
managed without treatment were analyzed to describe the presentation and outcome of a …
managed without treatment were analyzed to describe the presentation and outcome of a …
Watchful waiting in low-tumor burden follicular lymphoma in the rituximab era: Results of an F2-study database
P Solal-Ceĺigny, M Bellei… - Journal of Clinical …, 2012 - scholars.northwestern.edu
Purpose: Patients with follicular lymphoma (FL) registered in the F2-study and initially
managed without treatment were analyzed to describe the presentation and outcome of a …
managed without treatment were analyzed to describe the presentation and outcome of a …
Watchful Waiting in Low–Tumor Burden Follicular Lymphoma in the Rituximab Era: Results of an F2-Study Database
P Solal-Céligny, M Bellei, L Marcheselli… - Journal of Clinical …, 2012 - cir.nii.ac.jp
< jats: sec>< jats: title> Purpose</jats: title>< jats: p> Patients with follicular lymphoma (FL)
registered in the F2-study and initially managed without treatment were analyzed to describe …
registered in the F2-study and initially managed without treatment were analyzed to describe …
Watchful waiting in low-tumor burden follicular lymphoma in the rituximab era: results of an F2-study database.
P Solal Céligny, M Bellei, L Marcheselli… - JOURNAL OF …, 2012 - cris.unibo.it
PURPOSE: Patients with follicular lymphoma (FL) registered in the F2-study and initially
managed without treatment were analyzed to describe the presentation and outcome of a …
managed without treatment were analyzed to describe the presentation and outcome of a …
Watchful waiting in low-tumorburden follicular lymphoma in the Rituximab era. Results of a F2 observational
P Solal Céligny, M Bellei, L Marcheselli… - JOURNAL OF …, 2012 - iris.unimore.it
PURPOSEPatients with follicular lymphoma (FL) registered in the F2-study and initially
managed without treatment were analyzed to describe the presentation and outcome of a …
managed without treatment were analyzed to describe the presentation and outcome of a …
[引用][C] Watchful waiting in low-tumor burden follicular lymphoma in the rituximab era: results of an F2-study database
P SOLAL-CELIGNY - J Clin Oncol, 2012 - cir.nii.ac.jp